iScience
(Mar 2023)
Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
Francesca Colavita,
Valentina Mazzotta,
Gabriella Rozera,
Isabella Abbate,
Fabrizio Carletti,
Carmela Pinnetti,
Giulia Matusali,
Silvia Meschi,
Annalisa Mondi,
Daniele Lapa,
Serena Vita,
Claudia Minosse,
Camilla Aguglia,
Roberta Gagliardini,
Eliana Specchiarello,
Aurora Bettini,
Emanuele Nicastri,
Enrico Girardi,
Francesco Vaia,
Andrea Antinori,
Fabrizio Maggi
Affiliations
Francesca Colavita
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Valentina Mazzotta
Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Gabriella Rozera
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Isabella Abbate
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Fabrizio Carletti
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Carmela Pinnetti
Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Giulia Matusali
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy; Corresponding author
Silvia Meschi
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Annalisa Mondi
Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Daniele Lapa
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Serena Vita
Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Claudia Minosse
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Camilla Aguglia
Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Roberta Gagliardini
Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Eliana Specchiarello
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Aurora Bettini
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Emanuele Nicastri
Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Enrico Girardi
Scientific Direction, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Francesco Vaia
General Direction, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Andrea Antinori
Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy
Fabrizio Maggi
Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome 00149, Italy; Corresponding author
Journal volume & issue
Vol. 26,
no. 3
p.
106102
Abstract
Read online
Summary: We report the follow-up laboratory investigation of three MPXV cases infected in May-June 2022 from diagnosis to disease resolution, monitoring viral shedding in different body fluids and antibody kinetics. Out of 138 non-lesion samples, viral DNA was found in 92.3% saliva, 85.7% semen, 86.2% oropharyngeal swabs, 51.7% plasma, 46.1% stool, and 9.5% urine samples. Viral load quantified by digital PCR widely varied, but tend to be higher in oropharyngeal swabs, saliva, and stool. Replication competent virus was recovered from four out of seventeen samples, including 1 saliva, 1 oropharyngeal swabs, 1 semen, and 1 stool. The analysis of the antibody kinetics revealed that IgM, IgA, and IgG antibodies were detected within two weeks post-symptoms onset for all three patients, with IgG detected early on at day 4-8 and IgM and IgA showing lower titers along the time frame of the study. Antibody levels increased during the second week of illness with IgG reaching high titers.
Keywords
WeChat QR code
Close